CLX vs EOLS · P/E 15, rev $7.10B vs rev $266.3M
The Clorox Company (CLX) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the CLX and EOLS stock pages for the full models.
Not investment advice.